{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:39:17Z","timestamp":1758040757128,"version":"3.44.0"},"reference-count":2,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.amjmed.2022.01.021","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T03:58:51Z","timestamp":1653364731000},"page":"e132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Guidelines Are Meant to Guide, But They Are Not Absolute"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5505-1866","authenticated-orcid":false,"given":"James A.","family":"Reiffel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.amjmed.2022.01.021_bib0001","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.amjmed.2021.06.013","article-title":"Trends in calcium channel blocker use in patients with heart failure with reduced ejection fraction and comorbid atrial fibrillation","volume":"134","author":"Cholack","year":"2021","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2022.01.021_bib0002","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0002-9149(96)00860-0","article-title":"Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone","volume":"79","author":"Hansen","year":"1997","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:27:40Z","timestamp":1757582860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":2,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0002934322000936"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.01.021","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines Are Meant to Guide, But They Are Not Absolute","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}